{
    "id": 31334,
    "fullName": "PACSIN2 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PACSIN2-BRAF results from the fusion of PACSIN2 and BRAF, leading to reduced phosphorylation of Akt, activation of Mek1/2 and Erk1/2, and cytokine-independent proliferation in cell culture (PMID: 28748614). PACSIN2-BRAF has been identified in pediatric langerhans cell histiocytosis (PMID: 28748614).",
            "references": [
                {
                    "id": 16600,
                    "pubMedId": 28748614,
                    "title": "Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28748614"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 11252,
        "geneSymbol": "PACSIN2",
        "terms": [
            "PACSIN2",
            "SDPII"
        ]
    },
    "variant": "PACSIN2 - BRAF",
    "createDate": "10/25/2019",
    "updateDate": "10/25/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 18949,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a transformed cell line expressing a PACSIN2-BRAF fusion was not sensitive to treatment with Zelboraf (vemurafenib) in culture (PMID: 28748614).",
            "molecularProfile": {
                "id": 33679,
                "profileName": "PACSIN2 - BRAF"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 16600,
                    "pubMedId": 28748614,
                    "title": "Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28748614"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18948,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Cotellic (cobimetinib) inhibited viability of a transformed cell line expressing a PACSIN2-BRAF fusion in culture (PMID: 28748614).",
            "molecularProfile": {
                "id": 33679,
                "profileName": "PACSIN2 - BRAF"
            },
            "therapy": {
                "id": 1004,
                "therapyName": "Cobimetinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16600,
                    "pubMedId": 28748614,
                    "title": "Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28748614"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33679,
            "profileName": "PACSIN2 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}